Evaluating the cost-benefit profile of CPI stem cell therapy requires a comprehensive approach. Advocates often stress the possibility for substantial therapeutic gains, particularly in diseases where conventional therapies have proven ineffective. However, this is to consider the substantial financial burden associated with CPI stem cell therapy,